Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Human parvovirus 4 infections are primarily associated with parenteral exposure in western countries. By ELISA, we demonstrate frequent seropositivity for antibody to parvovirus 4 viral protein 2 among adult populations throughout sub-Saharan Africa (Burkina Faso, 37%; Cameroon, 25%; Democratic Republic of the Congo, 35%; South Africa, 20%), which implies existence of alternative transmission routes.

Original publication




Journal article


Emerg Infect Dis

Publication Date





1605 - 1607


Adolescent, Adult, Africa South of the Sahara, Aged, Antibodies, Viral, Burkina Faso, Cameroon, Capsid Proteins, Child, Democratic Republic of the Congo, Female, Humans, Male, Middle Aged, Parvoviridae Infections, Parvovirus, South Africa, Young Adult